Biotechnology AI agent · Product quality review
Product Quality Review Assembly AI Agent
Pull the review period's batch, deviation, out-of-specification, change, complaint, return and stability inputs into one pack, reconciled to the registers they came from — the conclusion stays with the heads who sign.
- Typical delivery
- 4–6 weeks
- Deployment
- Your stack
- Quality heads
- Pre-signature
- After launch
- Agent Care
What this agent does
Assembles the pack, not the conclusion
In
- 01
A period closes, and the batch list, deviation register, results, changes, complaints and returns pull in.
- 02
A register is read once and reconciled to the batch list, so two tables in one pack cannot disagree.
Reason
- 03
An input is normalised across the quality, manufacturing and laboratory systems, each figure kept with its source.
- 04
A closed deviation, CAPA or change arrives as an input from your quality-event work, and is reviewed, never reopened.
- 05
A failing result arrives already settled by the laboratory; whether it could be set aside was decided before this.
Decide
- 06
A variation granted mid-period is marked against the limit it moved, so no line is drawn across two specifications.
- 07
A previous open item travels forward with its owner, its due date and whether it moved since the last review.
Out
- 08
A US pack carries the basis of representativeness, because 21 CFR 211.180(e)(1) asks for a representative number.
- 09
Writes run only inside the approval boundaries agreed at implementation, and never onto a signed review.
Product statement
The agent assembles and makes no GMP determination; a named quality head concludes, and a second named person evaluates it.
Example workflow
One review period, inputs to signature
- 1Period closesBatch list, deviation register, LIMS extract, change log, complaints or stability data
- 2Inputs reconciledBatches, deviations, results, changes, complaints and stability points, each against its register
- 3Pack draftedElement coverage, reconciliation, trend picture, open items and confidence
- 4Controls appliedReconciliation checks, element-coverage checks, grouping checks and confidence threshold
No human action required
Stages 1 to 4 run unaided, and nothing is concluded at any of them — the agent is assembling, and the quality head's lane opens at the confidence gate.
Goes to the site quality head.
Adds a second quality read first.
Quality-head review
The pack is held with its inputs, its unreconciled lines and the confidence.
Sign · Query · Send for a second read
Signed — conclusion recorded
- 6Quality systems updatedOnly where write access and approval policy allow it
- 7Outcome evaluatedElement coverage, unreconciled lines, amendments and delivery against the agreement
Amendments
A pack read a year later is read against the registers, and that is what it has to survive.
What should not run autonomously
Human approval stays in control
Outside the boundary — human approval required
8 items
- Concluding that the process remains in control.
- Determining that CAPA or revalidation is due.
- Writing the conclusion for any review element.
- Deciding a grouping is scientifically justified.
Automation boundary
Agent acts unaided
- ✓Pull each element against the register it comes from.
- ✓Reconcile the batch list against the deviation and the result registers held.
- ✓Show the trend and the open items from the last review.
- ✓Test the pack for coverage and hold it for the signatories to read first.
Writes stay inside the boundaries set at implementation, and never onto a signed review.
- Reopening or closing a deviation or a change.
- Deciding whether a failing result may be set aside.
- Extending or waiving the date the agreement fixes.
- Changes to element, grouping or trend rules.
Example output
One element, annotated
What the agent assembles is attached to the register it was drawn from.
Review-pack output · single element
Illustrative example- Element
- Significant deviations
- Assembled line
- Four deviations in the period sit against batches outside the batch list this pack was built on
- Element cited
- EU GMP 1.10(iv)
- Register of record
- Deviation register
- Confidence
- 88%
- Owed to
- Contract-giver, by agreement
As received
Taken from the deviation register and the batch list — nothing on this side is written by the agent.
Inputs used
- Deviation register
- Batch list for the period
- Previous review actions
Why this element
It is the element the input has to satisfy and a person still decides.
What the score decides
Below the configured threshold the pack picks up a second quality read before it goes up.
Action
SignQuerySend for a second readValue
Where AI adds value
The same four claims, placed at the point in the workflow where each one applies.
Where the value lands
Value 01 – 04
Every element
From the source register
Start where the event is
The deviation, CAPA and change page closes the event; the OOS page settles the result. This one consumes both.
The conclusion is a signature
No instrument names a signatory. The signature exists because your procedure and technical agreement create it.
The deadline is contractual
EU GMP 1.11 requires a technical agreement between the parties, and that is the only place a review date exists at all.
Build an evidence trail
The input, the register it came from and the head who concluded stay on the review.
Integrations
Typical integrations
Five system groups connect to the same agent. Which of them are in scope is decided in discovery.
Quality management
- Veeva Vault QMS
- TrackWise
- MasterControl
- ETQ
Manufacturing records
- MES
- batch records
- SAP
- Oracle batch data
Laboratory systems
- LabWare
- STARLIMS
- LabVantage
- Empower
Agent
Product quality review
- Reads the registers
- Reconciles the inputs
- Holds for signature
Regulatory and stability
- Variations register
- Stability programme data
Observability & evaluation
- OpenTelemetry
- Langfuse
- Supported monitoring/evaluation sources
Integration availability depends on the client's existing systems and API access.
Agent controls
Six layers between the model and the review
Six checks stacked inward. Anything the whole stack misses is written into the map below.
L6 · Outermost — last line of defence
Inward → L1 · closest to the model
- L1 – L2
- Test whether a pack may stand
- L3
- Puts the conclusion in named hands
- L4 – L5
- Keep the input and the register behind it
- L6
- Holds the review at unconcluded when signals degrade
How Nestack evaluates it
Evaluate the assembly workflow — not only the signed pack.
Coverage runs the whole depth of the workflow, and every layer is cut by slice.
Surface — the pack the contract-giver reads
- E1Final-output evaluationDid each element carry its input, its register and its period?
- E2Step-level evaluationDid the agent use the right period, the right registers and the current template?
- E3Tool evaluationDid it read and write the correct product and the correct field?
- E4Confidence calibrationDo low-confidence packs actually attract more amendments in review?
- E5Slice evaluationHow does performance change across specific product families?
- E6Business outcomeHow many packs were amended, and how many went out late against the agreement?
Floor — the outcome the site answers for
Failure modes
Where each failure originates in the agent
Seven failure modes, each placed where in the lifecycle it starts.
Agent lifecycle
Direction of processing →
01 · Retrieval
1 mode
- FA-03
Register read as current
The list as it stands now, not as it stood then.
Stage gathers
Batch list, registers, results, changes and stability
02 · Reasoning
2 modes
- FA-04
Trend crosses a moved limit
A period is trended against a specification that changed.
- FA-06
Conclusion filled in
An assembly line reads as a conclusion it may not make.
Stage proposes
Coverage, reconciliation, trend and confidence
03 · Tool / write
2 modes
- FA-02
Pack issued unreconciled
Two tables in one pack count the period differently.
- FA-05
Open item carried unchanged
The previous open item repeats with no owner or date.
Stage writes
Only where write access and approval policy allow it
04 · Output
1 mode
- FA-01
Element left uncovered
A required element is absent and the pack still ships.
Stage returns
The pack the two named signatories read and sign
05 · Change / Version
1 mode
- FA-07
Silent element drift
A model or rule change drops a required element.
Stage tracks
Model, prompt, element list and trend-rule config
- Sev-1 · writes onto a signed review
- Sev-2 · an unreconciled pack is signed
- Sev-3 · a register degrades, the pack holds
Affected slices
The gaps concentrate in a few families
A site-level input-completeness figure can read as settled while a few product families carry most of the unreconciled inputs and the late packs. Nestack reports the unreconciled-input rate by family, not only in total.
Slice performance — reported separately, not only in aggregate
Illustrative example| Slice | Failure rate | Lift | Lift vs. threshold | Status |
|---|---|---|---|---|
| Contract-manufactured products | 6.3% | 3.6× | Review | |
| Campaign and seasonal products | 4.4% | 2.5× | Review | |
| Grouped dosage-form reviews | 3.3% | 1.9× | Watch | |
| Single-site routine products | 1.2% | 0.7× | Normal |
Bar: unreconciled-input-rate lift vs. the single-site routine baseline · scale 0–4.0× · tick marks the 2.0× review threshold
2 of 4 slices over threshold
Evidence-linked improvement
A cycle ends with one more test
A cycle closes when the missing input is a regression case. That suite is what the next review pack assembled is measured against.
Improvement cycle · five stages
Switchback — the path turns at Improve and returns at Learn
- 01
Detect
Unreconciled inputs rise in one family.
- 02
Diagnose
The review the contract-giver was owed in January and read in June is walked back until the cause narrows to one.
- 03
Improve
The fix carries a number, and the inputs that forced it travel with it.
- 04
Verify
Nothing goes out until every touched review case has passed again.
- 05
Learn
It is kept permanently, and the input rules are amended alongside it.
Learn → Detect
The return edge. Next time the detection runs against a longer suite.
Typical build scope
Twelve workstreams across six weeks
The build scope read against the delivery timeline. Week structure follows the six-week plan — discovery, sources, review workflow, evaluation, integration, then production validation and handover.
Workstream
Week 1Week 2Week 3Week 4Week 5Week 6
- 01Review-period workflow discovery and boundary work.Week 1
- 02Register and batch-list source assessment.Week 1, Week 2
- 03Element, grouping and trend procedure mapping.Week 1, Week 2
- 04Input ingestion and register mapping.Week 2
- 05Reconciliation logic and source binding.Week 2, Week 3
- 06Confidence scoring and exception routing.Week 3
- 07Quality-head sign-off workflow.Week 3, Week 4
- 08Register and batch-system integration.Week 5
- 09Input and trend cases.Week 4, Week 5
- 10Guardrails and conclusion controls.Week 4
- 11Review-trail instrumentation.Week 5, Week 6
- 12Deployment, documentation and Agent Care handover.Week 6
12 workstreams · 6 weeks · bar shows the weeks a workstream is active — several run in parallel
Final scope and sequence confirmed in discovery
Engagement tiers
What each tier includes
Rows are the capabilities named in each tier's scope. Higher tiers include everything below them.
| Capability✓ in scope · — not at this tier | PilotOne product, one site | ProductionProduction quality systems | AdvancedMultiple sites / partners |
|---|---|---|---|
| Introduced at Pilot | |||
| Assembly to your review template | ✓ | ✓ | ✓ |
| Quality-head sign-off | ✓ | ✓ | ✓ |
| Input-completeness baseline | ✓ | ✓ | ✓ |
| Introduced at Production | |||
| Reporting by product family | — | ✓ | ✓ |
| Sign-off workflow in your systems | — | ✓ | ✓ |
| Approved write-back | — | ✓ | ✓ |
| Register-and-batch integration | — | ✓ | ✓ |
| Introduced at Advanced | |||
| Complex element and template sets | — | — | ✓ |
| Multi-stage quality sign-off | — | — | ✓ |
| High product-count portfolios | — | — | ✓ |
| Multi-party review controls | — | — | ✓ |
| Build price | From $5,000 | From $8,000 | Custom quote |
- Final build price
- Confirmed after discovery based on integrations, workflow complexity, transaction volume, approval controls and deployment requirements.
- Separate from build
- Build pricing is separate from recurring Agent Care, which covers managed monitoring, evaluations, incidents and verified improvements after launch.
What we need from you
What you bring, and what we build with it
Each input maps to a piece of build scope and a week in the delivery timeline.
You bring
We build with it
01Your review template and element list
→Input ingestion and register mapping
Week 102Representative signed reviews
→Assembly baseline, element extraction and source binding
Week 203Your grouping and trend procedure
→Procedure mapping and automation-boundary definition
Week 104Access to relevant APIs, feeds or exports
→Register, batch and laboratory assessment, then integration setup
Week 205Reviews you would not want delivered late
→Input cases and the evaluation suite
Week 406What no review may conclude without
→Confidence scoring, exception routing, guardrails and sign-off controls
Week 307Named quality heads to review the pack
→Quality-head sign-off workflow, then pilot and production validation
Weeks 5–6
Nothing else is required
Deployment, documentation and Agent Care handover are ours.
Delivery timeline
Four phases across six weeks
Phase widths follow the calendar the work needs, so the doubling at week five is work, not padding.
Phase
W1
W2
W3
W4
W5
W6
- DiscoveryW1
- BuildW2 – W3
- EvaluateW4 – W5
- Pilot & LaunchW5 – W6
Week focus
W1Review discovery, procedure mapping and the automation boundary
W2Register integration and the assembly baseline
W3Assembly workflow, confidence logic and sign-off controls
W4Evaluation suite, guardrails and failure-mode testing
W5Laboratory and stability integration, pilot packs and corrections
W6One review period run under the quality head, then Agent Care handover
- Reading the band
- Each bar spans only the weeks its own work is named in. The week 5 overlap is two phases running, not padding.
- At the end of W6
- When the review pack validates, Agent Care takes the agent on.
- Duration
- Six-week plan shown · typical delivery 4–6 weeks depending on scope confirmed in discovery.
Next step · Biotechnology AI agent
Build a product quality review agent around your quality unit.
Show us your review template, your registers and who signs. The conclusion is carried by named people on both sides — the quality head at the manufacturer, and the person the marketing authorisation holder names to evaluate a review it did not write — and this agent never becomes either of them. What it does instead is narrow and checkable: it pulls each element against the register it came from, reconciles the batch list to the deviation, result, change, complaint, return and stability inputs, shows the trend those inputs make, and carries the previous review's open items forward with their owners and their dates. Here is what this page does not claim. It does not claim that a current review gates batch certification: EudraLex Annex 16, in operation 15 April 2016, enumerates the conditions a Qualified Person must secure before certifying, and a full-text check returns no occurrence of product quality review or annual product review anywhere in it. Where that dependency exists at your site, your own procedure or your technical agreement created it — and both bite: 21 CFR 211.180(e) requires written procedures to be established and followed, and EU GMP 1.11 requires the technical agreement that is the only place a review date exists at all. It does not claim regulators are coming for you either. We searched FDA warning letters for 2025 and 2026 and found no citation of 211.180(e) against a conventional drug manufacturer; the CDER Office of Compliance FY2025 report, published April 2026, does not break its counts down by CFR section; MHRA has published no GMP inspection deficiency data since 2016. We are not going to build a threat out of an absence of finding. The case here is contractual, and it is the stronger one: a contract-giver is owed this pack, on a date it set, in a template it dictated, from a party it can sue. On the frequency question, EMA has said since February 2015 that review timeframes can be appropriately adjusted for manufacturing and campaign duration with adequate justification; the revised EU GMP Chapter 1 out for joint European Commission and PIC/S consultation, closed 3 December 2025, codifies that and hardens the grouping rules, and remains draft with no final text located as at 20 August 2026. Draft EU/PIC/S GMP Annex 22 — consultation closed 7 October 2025, no final text located on the same date — says generative models should not be used in critical GMP applications, and this agent is built so that it is not one. The counterweight is MHRA's Inspectorate of 29 June 2026: GxP submissions must be technically reviewed by appropriately experienced people and signed off by someone with authority and accountability. If your quality-event work closes at the deviation and your laboratory work ends at the result, this is the year those registers have to agree across.
- Typical delivery
- 4–6 weeks
- Deployment
- Your registers and batches
- Quality heads
- Pre-signature
- After launch
- Agent Care available
Nestack Agents · Product quality review
AGT-BT-22 · Agent Care available after launch